PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Dream Team
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


SGOV 20%ABBNY 15%NVS 15%REL.L 15%ORA.TO 9%BNTX 8%AQX.L 7%NVO 3%AZN 3%RHHBY 2%SNY 1.2%NBIX 1%BondBondEquityEquity
PositionCategory/SectorTarget Weight
ABBNY
ABB Ltd
Industrials
15%
AMLX
Amylyx Pharmaceuticals, Inc.
Healthcare
0.20%
AQX.L
Aquis Exchange plc
Financial Services
7%
AZN
AstraZeneca PLC
Healthcare
3%
BNTX
BioNTech SE
Healthcare
8%
NBIX
Neurocrine Biosciences, Inc.
Healthcare
1%
NVO
Novo Nordisk A/S
Healthcare
3%
NVS
Novartis AG
Healthcare
15%
ORA.TO
Aura Minerals Inc.
Basic Materials
9%
REL.L
RELX PLC
Communication Services
15%
RGEN
Repligen Corporation
Healthcare
0.60%
RHHBY
Roche Holding AG
Healthcare
2%
SGOV
iShares 0-3 Month Treasury Bond ETF
Government Bonds
20%
SNY
Sanofi
Healthcare
1.20%

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Dream Team, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.


10.00%20.00%30.00%40.00%50.00%NovemberDecember2025FebruaryMarchApril
49.78%
12.95%
Dream Team
Benchmark (^GSPC)
Portfolio components

The earliest data available for this chart is Jan 7, 2022, corresponding to the inception date of AMLX

Returns By Period


YTD1M6M1Y5Y*10Y*
^GSPC
S&P 500
-10.18%-5.91%-9.57%5.19%12.98%9.68%
Dream Team12.37%0.24%8.48%28.72%N/AN/A
SGOV
iShares 0-3 Month Treasury Bond ETF
1.27%0.38%2.25%4.96%N/AN/A
NVO
Novo Nordisk A/S
-31.39%-27.12%-50.08%-52.43%14.90%9.99%
ABBNY
ABB Ltd
-2.37%-6.47%-9.15%15.68%28.48%13.62%
NVS
Novartis AG
18.03%-1.21%-1.42%23.39%9.98%6.75%
RHHBY
Roche Holding AG
15.23%-8.78%2.82%33.62%1.54%4.31%
AZN
AstraZeneca PLC
4.60%-12.30%-12.15%0.62%8.69%9.95%
SNY
Sanofi
5.54%-13.89%-7.22%10.39%4.39%3.44%
REL.L
RELX PLC
15.06%6.73%7.82%29.29%19.01%15.90%
BNTX
BioNTech SE
-13.33%-0.20%-13.72%14.31%19.70%N/A
NBIX
Neurocrine Biosciences, Inc.
-25.73%-7.58%-14.42%-23.91%0.49%8.99%
RGEN
Repligen Corporation
-9.68%-9.93%-8.54%-19.24%4.25%14.66%
AMLX
Amylyx Pharmaceuticals, Inc.
5.29%9.34%1.53%99.00%N/AN/A
ORA.TO
Aura Minerals Inc.
64.18%10.00%78.99%175.23%59.28%51.11%
AQX.L
Aquis Exchange plc
8.29%3.12%116.21%82.09%13.69%N/A
*Annualized

Monthly Returns

The table below presents the monthly returns of Dream Team, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20254.91%2.03%4.12%0.83%12.37%
20240.51%1.46%2.93%0.73%7.32%1.23%3.62%1.15%1.43%-2.37%2.47%-3.61%17.73%
20236.71%-2.97%4.89%4.13%-4.05%3.20%2.84%-2.85%-0.76%-1.74%7.40%3.73%21.53%
2022-1.75%-0.44%2.18%-4.91%1.15%-7.83%3.40%-4.16%-5.39%7.12%5.79%-1.05%-6.84%

Expense Ratio

Dream Team has an expense ratio of 0.01%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


Expense ratio chart for SGOV: current value is 0.03%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
SGOV: 0.03%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 97, Dream Team is among the top 3% of portfolios on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of Dream Team is 9797
Overall Rank
The Sharpe Ratio Rank of Dream Team is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of Dream Team is 9797
Sortino Ratio Rank
The Omega Ratio Rank of Dream Team is 9797
Omega Ratio Rank
The Calmar Ratio Rank of Dream Team is 9797
Calmar Ratio Rank
The Martin Ratio Rank of Dream Team is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for Portfolio, currently valued at 1.84, compared to the broader market-4.00-2.000.002.00
Portfolio: 1.84
^GSPC: 0.24
The chart of Sortino ratio for Portfolio, currently valued at 2.35, compared to the broader market-6.00-4.00-2.000.002.004.00
Portfolio: 2.35
^GSPC: 0.47
The chart of Omega ratio for Portfolio, currently valued at 1.36, compared to the broader market0.400.600.801.001.201.401.60
Portfolio: 1.36
^GSPC: 1.07
The chart of Calmar ratio for Portfolio, currently valued at 2.40, compared to the broader market0.001.002.003.004.005.00
Portfolio: 2.40
^GSPC: 0.24
The chart of Martin ratio for Portfolio, currently valued at 10.71, compared to the broader market0.005.0010.0015.0020.00
Portfolio: 10.71
^GSPC: 1.08

Portfolio components
Sharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
SGOV
iShares 0-3 Month Treasury Bond ETF
20.50471.26472.26482.387,657.62
NVO
Novo Nordisk A/S
-1.29-2.010.74-0.89-1.83
ABBNY
ABB Ltd
0.300.551.080.371.21
NVS
Novartis AG
0.941.341.190.901.90
RHHBY
Roche Holding AG
1.381.901.270.813.92
AZN
AstraZeneca PLC
-0.38-0.350.95-0.30-0.55
SNY
Sanofi
0.150.401.050.170.39
REL.L
RELX PLC
1.351.761.272.017.06
BNTX
BioNTech SE
0.270.821.090.200.97
NBIX
Neurocrine Biosciences, Inc.
-0.63-0.620.90-0.59-1.42
RGEN
Repligen Corporation
-0.41-0.280.97-0.38-1.17
AMLX
Amylyx Pharmaceuticals, Inc.
1.622.381.281.314.10
ORA.TO
Aura Minerals Inc.
4.133.931.559.1132.42
AQX.L
Aquis Exchange plc
0.544.301.891.194.84

The current Dream Team Sharpe ratio is 2.00. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Compared to the broad market, where average Sharpe ratios range from 0.21 to 0.77, this portfolio's current Sharpe ratio is in the top 25%, it signifies superior risk-adjusted performance. This means that for the level of risk undertaken, the portfolio is generating impressive returns compared to most others.

Use the chart below to compare the Sharpe ratio of Dream Team with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
1.84
0.24
Dream Team
Benchmark (^GSPC)
Portfolio components

Dividends

Dividend yield

Dream Team provided a 2.65% dividend yield over the last twelve months.


TTM20242023202220212020201920182017201620152014
Portfolio2.65%2.79%2.79%2.38%2.74%1.56%1.52%1.89%1.56%1.88%1.79%1.66%
SGOV
iShares 0-3 Month Treasury Bond ETF
4.79%5.10%4.87%1.45%0.03%0.05%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
2.78%1.68%1.00%1.20%1.34%1.86%2.14%2.47%2.12%3.93%1.31%1.96%
ABBNY
ABB Ltd
1.91%1.85%2.07%2.79%2.31%2.79%3.34%4.38%2.84%3.65%4.40%3.73%
NVS
Novartis AG
3.49%3.88%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%
RHHBY
Roche Holding AG
3.50%3.99%3.55%3.23%2.47%2.63%2.69%3.58%3.22%3.62%3.14%3.23%
AZN
AstraZeneca PLC
2.26%2.27%2.15%2.14%2.40%2.80%2.81%3.61%3.95%5.01%4.06%3.98%
SNY
Sanofi
4.00%4.22%3.83%4.22%3.80%3.61%3.46%4.29%3.67%4.03%3.79%4.19%
REL.L
RELX PLC
1.52%1.65%1.80%2.24%1.99%2.55%2.27%2.48%2.15%2.25%2.21%2.27%
BNTX
BioNTech SE
0.00%0.00%0.00%1.41%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NBIX
Neurocrine Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RGEN
Repligen Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AMLX
Amylyx Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ORA.TO
Aura Minerals Inc.
4.29%4.63%5.63%4.67%14.10%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AQX.L
Aquis Exchange plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-0.25%
-14.02%
Dream Team
Benchmark (^GSPC)
Portfolio components

Worst Drawdowns

The table below displays the maximum drawdowns of the Dream Team. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Dream Team was 20.75%, occurring on Sep 26, 2022. Recovery took 138 trading sessions.

The current Dream Team drawdown is 0.64%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-20.75%Jan 13, 2022182Sep 26, 2022138Apr 11, 2023320
-10.41%Mar 21, 202512Apr 7, 2025
-6.52%Aug 1, 202364Oct 27, 202319Nov 23, 202383
-5.04%Jul 15, 202417Aug 6, 20249Aug 19, 202426
-5.03%Dec 12, 20247Dec 20, 202429Feb 3, 202536

Volatility

Volatility Chart

The current Dream Team volatility is 8.62%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
8.62%
13.60%
Dream Team
Benchmark (^GSPC)
Portfolio components

Diversification

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

SGOVORA.TOAQX.LAMLXNBIXBNTXRGENNVOSNYREL.LABBNYRHHBYAZNNVS
SGOV1.00-0.04-0.03-0.04-0.02-0.02-0.030.010.00-0.020.010.010.030.03
ORA.TO-0.041.000.140.110.090.090.110.080.080.130.230.150.120.10
AQX.L-0.030.141.000.050.040.100.180.100.150.310.290.170.170.22
AMLX-0.040.110.051.000.290.220.280.160.110.080.190.150.140.16
NBIX-0.020.090.040.291.000.230.260.220.130.110.170.180.230.23
BNTX-0.020.090.100.220.231.000.320.190.220.160.250.190.250.23
RGEN-0.030.110.180.280.260.321.000.240.120.250.350.220.210.18
NVO0.010.080.100.160.220.190.241.000.290.240.270.280.410.36
SNY0.000.080.150.110.130.220.120.291.000.260.220.360.490.53
REL.L-0.020.130.310.080.110.160.250.240.261.000.420.350.330.37
ABBNY0.010.230.290.190.170.250.350.270.220.421.000.290.280.29
RHHBY0.010.150.170.150.180.190.220.280.360.350.291.000.440.52
AZN0.030.120.170.140.230.250.210.410.490.330.280.441.000.55
NVS0.030.100.220.160.230.230.180.360.530.370.290.520.551.00
The correlation results are calculated based on daily price changes starting from Jan 10, 2022
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab